American Healthcare REIT, Inc. (AHR): Results of Operations and Financial Condition
American Healthcare REIT, Inc. (AHR) filed an SEC Form 8-K — Results of Operations and Financial Condition. E Exhibit 99.1 Press Release Irvine, CA – August 6, 2026 Contact: Alan Peterson Email: investorrelations@ahcreit.com American Healthcare REIT Announces Second Quarter 2026 Results; Increases Full Year 2026 Guidance American Healthcare REIT, Inc. (NYSE: AHR) (the “Company,” “we,”
How this was made
The 30-second read
Why it matters
Because the excerpt contains no numeric results, guidance, or balance-sheet changes, it does not provide a concrete trading catalyst.
Market read
This is a regulatory filing update, but the excerpt does not include the actual performance figures or guidance that would drive trading decisions.
What to watch
Traders should review the full Exhibit 99.2 for the actual Q2 2026 metrics (FFO/NFFO, NOI, occupancy, same-store NOI, leverage/net debt, and any full-year guidance changes).
Normalized FFO per diluted share increased 28.6% to $0.54 and total Same-Store NOI increased 13.2% to $112,286 in Q2 2026.
The reported quarter showed double-digit Same-Store NOI growth across the total portfolio, ISHC and SHOP, with higher NAREIT FFO and Normalized FFO per diluted share, higher ISHC cash NOI margin, and positive same-store occupancy gains.
Key metrics
as reported| Metric | Value | q/q | y/y |
|---|---|---|---|
| NAREIT FFO per share - dilutednon-GAAP | $0.51 | – | 24.4% |
| Normalized FFO per share - dilutednon-GAAP | $0.54 | – | 28.6% |
| YTD NAREIT FFO per share - dilutednon-GAAP | $0.99 | – | 28.6% |
| YTD Normalized FFO per share - dilutednon-GAAP | $1.05 | – | 31.3% |
| Total Same-Store NOInon-GAAP | $112,286 | – | 13.2% |
| YTD Total Same-Store NOInon-GAAP | $219,320 | – | 12.7% |
| ISHC cash revenueother | $510,809 | – | – |
| ISHC operating expensesother | 426,226 | – | – |
| ISHC Cash NOInon-GAAP | $84,583 | – | – |
| ISHC Cash NOI Margin %non-GAAP | 16.6% | – | – |
| ISHC total average Occupancyother | 89.5% | – | – |
| ISHC Same-Store NOInon-GAAP | $71,350 | – | 16.1% |
| ISHC Same-Store NOI Margin %non-GAAP | 21.1% | – | 177 bps |
| ISHC Same-Store revenueother | $337,499 | – | 6.4% |
| ISHC Same-Store operating expensesother | 266,149 | – | 4.1% |
| ISHC maintenance capexother | $5,606 | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Integrated Senior Health Campuses (ISHC)ISHC Same-Store revenue increased 6.4% to $337,499, while Same-Store operating expenses increased 4.1% to 266,149 and Same-Store NOI increased 16.1% to $71,350. | $510,809 | – | – |
What drove it
- Total Same-Store NOI increased 13.2% to $112,286, led by ISHC growth of 16.1% and SHOP growth of 20.5%.
- ISHC Same-Store revenue increased 6.4% to $337,499, exceeding the 4.1% increase in Same-Store operating expenses.
- ISHC Same-Store total average Occupancy increased 180 bps to 90.7%.
- ISHC Same-Store NOI margin increased 177 bps to 21.1%.
- SHOP Same-Store NOI increased 20.5% to 16,087.
Concerns
- OM Same-Store NOI increased 1.7% to 17,391, below the growth reported for ISHC and SHOP.
- ISHC total portfolio average Occupancy was 89.5%, compared with 89.9% in Q1 2026.
- ISHC campuses declined to 148 in Q2 2026 from 149 in Q1 2026, and SNF beds declined to 8,137 from 8,275.
- ISHC maintenance capex was $5,606, compared with $4,657 in Q1 2026 and $3,711 in Q2 2025.
What to watch
- Whether ISHC Same-Store occupancy and the 21.1% Same-Store NOI margin can be sustained.
- The pace of SHOP Same-Store NOI growth following the reported 20.5% increase.
- OM Same-Store NOI growth after its reported 1.7% increase.
- Portfolio occupancy, property count and beds/units following the sequential decline in ISHC campuses and SNF beds.
- Any full year 2026 guidance figures, which are referenced in the supplemental but not provided in the supplied filing text.
Balance sheet and cash flow
- Interest Coverage Ratio: 7.1X
- Fixed Charge Coverage Ratio: 5.5X
- Net Debt-to-Annualized Adjusted EBITDA: 2.5X
- Total Pro-Rata Annualized Cash NOI: $571,840
- ISHC Pro-Rata Annualized Cash NOI: $338,332
- SHOP Pro-Rata Annualized Cash NOI: 125,868
- OM Pro-Rata Annualized Cash NOI: 73,124
- Triple-Net Leased Properties Pro-Rata Annualized Cash NOI: 29,832
- Debt Security Investment Pro-Rata Annualized Cash NOI: 4,684
Analysis
American Healthcare REIT reported strong operating momentum in Q2 2026. Total Same-Store NOI increased 13.2% to $112,286, while NAREIT FFO per diluted share increased 24.4% to $0.51 and Normalized FFO per diluted share increased 28.6% to $0.54. Year-to-date growth was also positive, with NAREIT FFO per diluted share of $0.99 and Normalized FFO per diluted share of $1.05.
ISHC was the principal reported operating contributor. ISHC Same-Store NOI increased 16.1% to $71,350 as Same-Store revenue increased 6.4% to $337,499 and Same-Store operating expenses increased 4.1% to 266,149. The spread between revenue and expense growth supported a 177 bps increase in ISHC Same-Store NOI margin to 21.1%. ISHC Same-Store total average Occupancy increased 180 bps to 90.7%.
The broader same-store portfolio showed growth across each disclosed property category, although the pace varied. SHOP Same-Store NOI increased 20.5% to 16,087, ISHC increased 16.1% to $71,350, Triple-Net Leased Properties increased 2.1% to 7,458, and OM increased 1.7% to 17,391. The relatively modest OM result is the key contrast with the stronger senior-housing-related growth.
At the total ISHC portfolio level, cash revenue was $510,809 and Cash NOI was $84,583, with a Cash NOI Margin of 16.6%. Total portfolio average Occupancy of 89.5% was below the 89.9% reported for Q1 2026, while ISHC campuses fell to 148 from 149 and SNF beds fell to 8,137 from 8,275. These changes, together with maintenance capex of $5,606, warrant monitoring against the stronger same-store results.
Balance-sheet coverage metrics reported in the supplemental were an Interest Coverage Ratio of 7.1X, a Fixed Charge Coverage Ratio of 5.5X, and Net Debt-to-Annualized Adjusted EBITDA of 2.5X. The supplied filing text contains no quantified forward guidance, cash balance, debt balance, dividend, share-repurchase activity, GAAP income statement figures, or operating cash flow figures, so the reported operating trajectory cannot be assessed against a stated numerical outlook.
Not in the filing
stated, not guessed- GAAP total revenue
- GAAP gross margin
- GAAP operating income
- GAAP net income or loss attributable to common stockholders
- GAAP earnings per diluted share
- GAAP cash flows from operating activities
- Free cash flow
- Cash and cash equivalents balance
- Total debt balance
- Dividend declaration or payment information
- Share repurchase activity
- Quantified full year 2026 guidance
- Prior-period guidance for comparison
- Revenue for SHOP, OM, Triple-Net Leased Properties and Debt Security Investment
- Segment-level GAAP revenue
- Quarter-over-quarter percentage changes for reported FFO, NOI, revenue, expenses, margins and occupancy metrics
- Year-over-year percentage changes for ISHC total portfolio cash revenue, operating expenses, Cash NOI, Cash NOI Margin and maintenance capex
- Named executive quotes
AlphaAI analysis generated from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure was cross-checked against the filing text; consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.
Background
The SEC 8-K indicates AHR issued a Second Quarter 2026 supplemental (Exhibit 99.2) alongside its earnings press release, but the provided content is only disclaimers and non-GAAP measure explanations.
Ticker impact
AHR filed an 8-K with a Second Quarter 2026 supplemental on results of operations and financial condition, but the provided text contains only boilerplate definitions and disclaimers.
Likely negligible immediate impact from this excerpt; price reaction would depend on the missing exhibit 99.2 numeric results and guidance details.
The excerpt is primarily forward-looking statement and non-GAAP measure definitions, with no disclosed earnings, FFO/NFFO, NOI, occupancy, guidance numbers, or balance-sheet changes.
Market effects
None from the provided excerpt; it does not disclose REIT operating trends, portfolio metrics, or guidance.
None from the provided excerpt.
None from the provided excerpt.
Counterpoint
The filing may still be market-moving, but the excerpt omits the actual results and guidance, so this brief cannot confirm any catalyst.
Key entities
- issuerAmerican Healthcare REIT, Inc.
Subject of the SEC 8-K filing and the accompanying Second Quarter 2026 supplemental exhibit.
- filingSEC Form 8-K
Regulatory filing type used to report results of operations and financial condition.
